ImpediMed Limited (IPDQF)
OTCMKTS · Delayed Price · Currency is USD
0.0140
-0.0030 (-17.65%)
Feb 11, 2026, 9:30 AM EST

ImpediMed Revenue

In the fiscal year ending June 30, 2025, ImpediMed had annual revenue of 12.72M AUD with 23.31% growth. ImpediMed had revenue of 6.72M in the half year ending June 30, 2025, with 18.05% growth.

Revenue
12.72M AUD
Revenue Growth
+23.31%
P/S Ratio
3.12
Revenue / Employee
165.25K AUD
Employees
77
Market Cap
26.03M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202512.72M2.41M23.31%
Jun 30, 202410.32M-1.03M-9.04%
Jun 30, 202311.34M778.00K7.36%
Jun 30, 202210.57M2.16M25.65%
Jun 30, 20218.41M2.67M46.47%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
QHSLab2.61M
PetVivo Holdings1.41M
Positron486.45K
Guided Therapeutics178.00K
CS Diagnostics98.73K
Vivos48.62K
ALR Technologies SG25.54K
REMSleep Holdings6.73K
Revenue Rankings